Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kortekaas

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Vaccine|July 23, 2014
Comparative efficacy of two next-generation Rift Valley fever vaccinesJ Kortekaas, N Oreshkova, L van Keulen, et al.
Journal of Virology|September 28, 2012
Heparan sulfate facilitates Rift Valley fever virus entry into the cellS M de Boer, J Kortekaas, C A M de Haan, et al.
Vaccine|January 9, 2010
Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challengeS M de Boer, J Kortekaas, A F Antonis, et al.
Vaccine|January 19, 2010
Intramuscular inoculation of calves with an experimental Newcastle disease virus-based vector vaccine elicits neutralizing antibodies against Rift Valley fever virusJ Kortekaas, A Dekker, S M de Boer, et al.
Vaccine|March 28, 2012
Efficacy of three candidate Rift Valley fever vaccines in sheepJ Kortekaas, A F G Antonis, J Kant, et al.
Lung Cancer (Amsterdam, Netherlands)|July 20, 2019
Guideline adherence of mediastinal staging of non-small cell lung cancer: A multicentre retrospective analysisJelle E Bousema, Martijn van Dorp, Fieke Hoeijmakers, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Vaccine|July 23, 2014
Comparative efficacy of two next-generation Rift Valley fever vaccinesJ Kortekaas, N Oreshkova, L van Keulen, et al.
Journal of Virology|September 28, 2012
Heparan sulfate facilitates Rift Valley fever virus entry into the cellS M de Boer, J Kortekaas, C A M de Haan, et al.
Vaccine|January 9, 2010
Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challengeS M de Boer, J Kortekaas, A F Antonis, et al.
Vaccine|January 19, 2010
Intramuscular inoculation of calves with an experimental Newcastle disease virus-based vector vaccine elicits neutralizing antibodies against Rift Valley fever virusJ Kortekaas, A Dekker, S M de Boer, et al.
Vaccine|March 28, 2012
Efficacy of three candidate Rift Valley fever vaccines in sheepJ Kortekaas, A F G Antonis, J Kant, et al.
Lung Cancer (Amsterdam, Netherlands)|July 20, 2019
Guideline adherence of mediastinal staging of non-small cell lung cancer: A multicentre retrospective analysisJelle E Bousema, Martijn van Dorp, Fieke Hoeijmakers, et al.
Pageof 2